Related Experiment Video
Updated: Dec 17, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
Frederick M Lang1, Kevin M-C Lee2, John R Teijaro3
1Roivant Sciences Inc., New York, NY, USA.
Insights
Therapeutics for COVID-19 are needed. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has contrasting roles, with both its administration and inhibition being explored in clinical trials.
Area of Science:
- Immunology
- Pulmonology
- Infectious Diseases
Background:
- Coronavirus disease 2019 (COVID-19) necessitates novel therapeutic strategies.
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a key regulator of immune responses in the lungs.
- GM-CSF influences alveolar macrophage function, lung inflammation, and immune pathology.
Purpose of the Study:
- To review the multifaceted biological functions of GM-CSF.
- To evaluate the rationale for both stimulating and inhibiting GM-CSF in COVID-19.
- To discuss the ongoing clinical investigations of GM-CSF-based therapies for COVID-19.
Main Methods:
- Literature review of GM-CSF biology.
- Analysis of scientific evidence supporting therapeutic interventions.
- Discussion of current clinical trial data.
Main Results:
- GM-CSF exhibits diverse roles in immune cell regulation and inflammation.
- Evidence suggests potential benefits for both GM-CSF administration and inhibition in different COVID-19 contexts.
- Clinical trials are actively investigating these opposing therapeutic strategies.
Conclusions:
- The complex biology of GM-CSF presents unique challenges and opportunities for COVID-19 treatment.
- Targeting GM-CSF offers a promising avenue for developing effective COVID-19 therapeutics.
- Further research is crucial to elucidate the optimal use of GM-CSF modulation in managing COVID-19.
Abstract:
Therapeutics against coronavirus disease 2019 (COVID-19) are urgently needed. Granulocyte-macrophage colony-stimulating factor (GM-CSF), a myelopoietic growth factor and pro-inflammatory cytokine, plays a critical role in alveolar macrophage homeostasis, lung inflammation and immunological disease. Both administration and inhibition of GM-CSF are currently being therapeutically tested in COVID-19 clinical trials. This Perspective discusses the pleiotropic biology of GM-CSF and the scientific merits behind these contrasting approaches.
More Related Videos
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Psychosis: Goals of Pharmacotherapy
Group Therapy
Heart Failure VI: Adjunct Therapies
Microorganisms in Medicine and Therapeutics
COPD: Management Using Bronchodilators and Corticosteroids

